I
ntracranial aneurysms are common, with a prevalence of 0.5% to 6% in adults, according to angiography and autopsy studies. 1 Most intracranial aneurysms are asymptomatic and are never detected. Some are discovered incidentally in neuroimaging studies and some produce symptoms due to compression of neighboring nerves or adjacent brain tissue. Others are detected only after they have ruptured and caused subarachnoid hemorrhage, a devastating type of stroke associated with 32% to 67% case fatality and 10% to 20% long-term dependence in survivors due to brain damage. 2 To prevent subarachnoid hemorrhage, physicians have developed methods to treat aneurysms. For ruptured aneurysms, early treatment within 24 to 72 hours has been recommended because the risk of subsequent rupture is high, with approximately 20% risk of rerupture in the first 2 weeks after subarachnoid hemorrhage. 3 Each additional rupture substantially increases the risk of mortality and morbidity. Treatment has also been recommended for most unruptured aneurysms, 4 although there is uncertainty about treatment of some small aneurysms Ͻ10 mm because their risk of rupture appears low. 5, 6 The American Heart Association formed this special writing group to summarize the literature and create recommendations on endovascular therapy of ruptured and unruptured intracranial aneurysms. This statement is meant to extend previous statements on treatment of subarachnoid hemorrhage 3 and on treatment of unruptured aneurysms. 4 During the review, it became evident that any recommendations would be based primarily on expert opinion weighing evidence only from nonrandomized cohort studies and case series.
Background
In 1937, Walter Dandy reported the first successful surgical clipping of the neck of an aneurysm. Microsurgical techniques have steadily evolved since then, with development of a variety of surgical approaches and metal aneurysm clips. Repair of aneurysms in nearly all intracranial locations is possible by placing a clip made from a stable metal (including platinum, titanium, tungsten, and steel alloys) across the neck of the aneurysm, thus excluding it from the cerebral circulation.
Endovascular treatment of intracranial aneurysms was first described in the early 1970s by Fedor Serbinenko, a Russian neurosurgeon. 7, 8 He used a vascular catheter with a detachable latex balloon to treat aneurysms, either by depositing the balloon directly into the aneurysm lumen or by occluding the artery from which the aneurysm arose.
In 1991, Guido Guglielmi was the first to describe the technique of occluding aneurysms from an endovascular approach with electrolytic detachable platinum coils, termed Guglielmi detachable coils (GDCs). 9, 10 GDCs are introduced directly into the aneurysm through a microcatheter and detached from a stainless-steel microguidewire by an electrical current (Figure 1 ). The aneurysm is packed with 1 or more GDCs, thereby excluding it from the circulation ( Figure 2) .
As clinical experience with this technique has increased and coil design has improved, coil embolization has been used with increasing frequency even in patients who could be treated by conventional surgical clipping. 11, 12 Furthermore, some centers are treating patients with surgical clipping only if they cannot be treated primarily by endovascular coil embolization therapy. 13 In August 2002, it was estimated that 100 000 patients with intracranial aneurysms had been treated with GDCs at sites throughout the world, with approximately 1500 patients being treated per month. 14 Given the wide use of endovascular coil embolization to treat intracranial aneurysms, it is important to establish recommendations, based on the best available evidence, to define appropriate indications for coil embolization and other endovascular techniques in the context of surgical alternatives. The essential elements to compare are risk of morbidity and mortality, and efficacy, measurable in terms of reduced risk of aneurysm rupture after treatment.
Procedural Risk
Intracranial aneurysm treatment, by either surgery or endovascular coiling, may precipitate a complication that could lead to new symptoms, disability, or death. In comparing procedural risks, a measure of complications caused by the treatment itself would be ideal so that the impact of the therapy could be isolated from other aspects of presentation or medical care. For example, brain injury from subarachnoid hemorrhage at presentation or from aspiration of gastric contents during airway manipulation may lengthen hospitalization or result in disability, and these complications could obscure the impact of the procedure itself on outcomes. However, determinations of what "procedure-related" means are subjective and require judgment; hence, "measurements" of procedure-related complications are unreliable. In formulating these guidelines, we have favored comparisons of functional outcomes when available in the literature.
Functional outcomes after subarachnoid hemorrhage are highly dependent on the severity of the initial hemorrhage. 15 Although researchers have attempted to adjust for differences in pretreatment prognosis, it is not possible to ensure that adjustment is adequate to compare results in different case series. Thus, comparison of results of case series of procedural risk in ruptured aneurysm treatment should be avoided.
As with all procedures, risk is affected by patient selection, technical expertise, and supportive services, and its measurement is influenced by the definition of the outcome and the judgment of the evaluator. Descriptions of retrospective case series, which dominate the literature on procedural risk of intracranial aneurysm treatment either by surgery or by endovascular coiling, should be considered skeptically given potential sources of bias and will be reviewed only briefly. Comparative studies that include patients treated by both modalities are more likely to assess outcomes impartially and may provide more reliable comparisons of surgery and endovascular coil embolization. Results of randomized trials of adequate size are not currently available.
Surgical Series
A recent meta-analysis of surgery for unruptured intracranial aneurysms included results of 2460 cases described in 61 reports published between January 1966 and June 1996. 16 The mortality rate was 2.6% and permanent morbidity was 10.9%, which was variably defined in the included reports. A large, international prospective study of unruptured aneurysm treatment included 995 surgically treated patients. 5 At 1-year follow-up, surgical mortality was 3.2%. Disability was present in 12.0%: 5.8% had moderate or severe disability and 6.1% had isolated cognitive impairment. Thus, the combined morbidity and mortality rate with surgery for unruptured cerebral aneurysms was 15.2% at 1 year, or 9.0% when limited to moderate disability or worse. Cognitive function has not been measured carefully in other studies.
Endovascular Series
The procedural risk of endovascular coil embolization was recently reviewed in a meta-analysis of case series reported from January 1990 through March 1997. 17 Ninety patients with unruptured aneurysms were included, of whom 73 had follow-up evaluations. The mortality rate was 1.4% and an additional 1.4% had moderate or severe disability, but these rates are unreliable given the small number studied. In addition, 16.7% were noted to have ischemic complications, which resulted in a permanent deficit in 6.7%. The combined permanent morbidity and mortality for endovascular coiling was therefore 8.1%, or 2.8% if limited only to moderate disability or worse. Although a large, international prospective study of unruptured aneurysms included a number of patients treated with coil embolization, 5 results for this procedure have not been published, and whether coil embolization impacts cognitive function is unknown.
Comparative Studies
No randomized trial of unruptured aneurysm treatment has yet been performed. A single randomized trial comparing the surgical clipping and endovascular coil embolization of ruptured aneurysms has been published, however. 18, 19 This single-center study enrolled 109 patients. Outcomes were not significantly different at 3-month and 1-year follow-up, but only an extremely large treatment effect would have been apparent with this small sample size.
The ongoing International Subarachnoid Aneurysm Trial (ISAT), which involves 42 centers in Europe and North America, is expected to complete recruitment of 2500 patients in late 2002. 20 This sample size will be adequate to detect a 25% difference in proportions with moderate or worse disability.
A study of administrative data from 70 academic medical centers in the United States compared treatment risks in 2612 patients treated for unruptured aneurysms from 1994 through 1997. 21 The primary outcome, in-hospital death or discharge to a nursing home or rehabilitation center, was less frequent in those treated with endovascular coil therapy (endovascular 10.6% versus surgery 18.5%; Pϭ0.002). In-hospital death was also lower (endovascular 0.4% versus surgery 2.3%; Pϭ0.039), but the difference was not significant after adjustment for other prognostic factors.
A similar study of administrative data included 2069 patients with unruptured aneurysms treated in California from 1990 through 1998. 12 Adverse outcomes, defined as inhospital death or discharge to a nursing home or rehabilitation center, were less frequent in those treated with endovascular therapy (10% versus 25% with surgery; PϽ0.001), as was the risk of in-hospital death (0.5% versus 3.5%; PϽ0.001). These differences persisted after adjustment for other prognostic factors.
A single-center study reported results of 130 patients with unruptured aneurysms who were considered candidates for both surgical clipping and endovascular coil embolization. 11 A change of 2 or more points in the Rankin Scale, indicative of a new moderate disability or worse, 22 occurred in 8% of cases treated with endovascular therapy and in 25% of cases treated by surgical clipping (Pϭ0.01). Practitioners blinded to actual treatment and outcome judged pretreatment risks within the 2 groups to be comparable.
Another single-center study compared surgery and endovascular therapy of ruptured and unruptured basilar terminus aneurysms in 41 patients who were considered candidates for either procedure. 23 Only 15 patients were treated for unruptured aneurysms, and outcome differences did not reach significance.
No difference in overall outcome was detected after the introduction of coil embolization as a treatment option for intracranial aneurysms at a single center. 24 However, 2 studies of administrative data have shown improved outcomes for intracranial aneurysm treatment at hospitals that use endovascular therapy in a larger portion of patients. 12, 25 
Conclusions
Observational studies provide the only useful information about the relative risks of surgery and endovascular coil embolization in the treatment of ruptured and unruptured intracranial aneurysms. Although most comparative studies have suggested that coil embolization is safer, others have not, and all studies are limited by the possibility that patient selection is contributing to outcome differences.
Procedural Efficacy
The primary goal of any treatment for intracranial aneurysms is to reduce the risk of initial or recurrent subarachnoid hemorrhage; therapies for repair of either ruptured or unruptured aneurysms are based on this principle. The appearance of a fully occluded aneurysm after its treatment should not be considered a reliable surrogate for risk of subsequent aneurysm rupture without clear evidence correlating the degree of occlusion with subsequent rupture rates: complete occlusion may not be required to reduce rupture rates or may not be adequate. Furthermore, some unruptured aneurysms are at low risk of rupture when left untreated. 5 Therefore, efficacy of therapy may be evaluated most efficiently by comparing subarachnoid hemorrhage rates after treatment of ruptured aneurysms. Short-term reductions in rerupture rates may not persist, so it is important to evaluate long-term risks. Calculation of the rate requires a tally of the number of new events and of the total person-years of follow-up observation, which has been reported in only a small number of studies (Table) .
Surgical Clipping
Three studies have reported rates of rerupture after surgical clipping of ruptured aneurysms 18, 26, 27 and 1 other reported mortality from rerupture. 28 In a recent review of the literature on aneurysm growth and hemorrhage after surgical clipping of ruptured and unruptured aneurysms, there were 6 hemorrhages after treatment of 1397 patients, but duration of follow-up was not reported. 29 One small series of distal basilar artery aneurysms 23 documented no reruptures in surgically clipped aneurysms during 32.5 patient-years of follow-up. Other reports have documented subarachnoid hemorrhage after surgical clipping of previously ruptured aneurysms but did not provide adequate detail to determine annual rates of rupture. 30 -38 
Coil Embolization
Several case series have documented rates of subarachnoid hemorrhage after coil embolization of ruptured aneurysms. Six studies included ruptured aneurysms in all locations and provide adequate information to calculate annual rerupture rates (Table) . 18,39 -43 Combining these 6 studies, a rerupture rate of 0.9% per year is estimated after coil embolization of ruptured aneurysms in various locations.
Four studies have provided detailed information on hemorrhage after coil embolization of ruptured aneurysms arising from the posterior circulation. In a study of 34 ruptured distal basilar artery aneurysms, there was a single rerupture of an incompletely occluded aneurysm during 74.8 patient-years of follow-up, corresponding to a rate of 1.3% per year. 44 Another study of 61 patients, who were followed for a mean of 1.1 years after treatment, found an annual rerupture rate of 2.9%. 45 Another study documented no reruptures during approximately 24 patient-years of follow-up. 23 A study that included 104 patients with ruptured posterior circulation aneurysms documented a single rerupture, with an annual rate of 0.9%. 46 Combining these studies, a 1.4% annual rerupture rate is estimated for aneurysms arising from the posterior circulation, primarily from the distal basilar artery.
Several series have noted that larger aneurysms were more likely to recur and present with hemorrhage after treatment. In a cohort study of previously ruptured aneurysms more than 2 cm in diameter, 1 rerupture occurred in 36.6 patient-years of follow-up, corresponding to an annual rupture rate of 2.7%. 47 Other case series have noted subarachnoid hemorrhages during long-term follow-up after coil embolization, but either have not provided length of follow-up or have not distinguished between ruptured and unruptured aneurysms at the time of initial treatment. 48 -57 Therefore, it is not possible to calculate rates of rerupture from this group of publications. In 1 of these reports, an overall annual hemorrhage rate of 1.8% was reported after coil embolization in a consecutive series of ruptured and unruptured aneurysms. 49 Aneurysm size was an important predictor of hemorrhage risk, with 33% of giant aneurysms, 4% of large aneurysms, and no small aneurysms presenting with new hemorrhage during an average of 3.5 years' follow-up. Another similar series found an overall annual hemorrhage rate of 1.4% over 141 patient-years, with degree of occlusion an important predictor. 56 
Procedural Efficacy: Studies Measuring Rerupture Rates From Treated Ruptured Aneurysms

Occlusion Rates
Case reports and series have shown that even aneurysms that appear completely occluded after surgery or endovascular coil embolization may later rupture. 26, 48, 58 However, the majority of hemorrhages after treatment reported in patients with postprocedural angiography have occurred in incompletely occluded aneurysms, and aneurysm growth appears to be more frequent when complete occlusion is not achieved, with an incidence of 49% in 1 series of 178 incompletely occluded aneurysms. 59 Angiographic follow-up may reveal return of blood flow into an aneurysm and provide an opportunity to further treat an aneurysm before it becomes symptomatic. 59, 60 Therefore, although the degree of aneurysm obliteration does not appear to be an adequate surrogate for hemorrhage risk after treatment, it may be an important goal of treatment by both endovascular coil embolization and surgical clipping.
Complete occlusion is not possible on first endovascular treatment in a significant portion of intracranial aneurysms. 17 In meta-analysis, only 54% of aneurysms were completely occluded after initial coil embolization, with 88% more than 90% occluded. 17 Follow-up angiography and additional coil embolization are required to completely occlude many aneurysms by endovascular means. Coils in an incompletely treated aneurysm may make it more difficult to obtain complete occlusion with surgical clipping. Complications and inconveniences of follow-up care should therefore be considered in making treatment decisions and in comparing outcomes of procedures.
Compressive Symptoms
Although reduction of risk of rupture is the primary reason for intracranial aneurysm treatment, relief of symptoms due to mass effect may also be important. Coil embolization relieved symptoms and signs of mass effect in more than 90% of cases in a series of 26 patients. 61 However, improvements were less dramatic in a second series of 16 patients with aneurysms compressing cranial nerves, in which coil embolization resulted in improvement in 74% and worsening in 5%. 62 
Conclusions
All reported series of long-term follow-up after coil embolization or surgical clipping of intracranial aneurysms are likely to contain biases. Because sudden death is common after subarachnoid hemorrhage and cause of death may go undiagnosed, true hemorrhage rates are likely higher than those reported in the literature. In addition, efforts to obtain follow-up information on all treated patients have been variable.
Rates of rerupture in untreated ruptured aneurysms are high, with studies documenting 20% to 30% risk in the first month and approximately 3% per year thereafter. 3 Both surgical clipping and endovascular coil embolization appear to reduce this risk, but evidence is sparse in the delayed period. Further studies with long-term follow-up are required to compare the efficacy of these procedures.
Therapy Selection
Selection of endovascular coil embolization or surgery for a particular patient should depend on an individualized determination of relative risks and likelihood of complete occlusion. Characteristics of the aneurysm and patient may influence the final treatment decision. Other key factors are the location of the aneurysm and its size, and contraindications to radiographic contrast, such as known allergy or renal failure.
Aneurysm Location
Middle cerebral artery aneurysms are frequently difficult to treat by coil embolization, 11, 13, 63 and surgical results for these aneurysms are often reported as more favorable than in other locations. 28, 64, 65 Aneurysms in the posterior cerebral circulation, however, are difficult to treat with surgery, 16 and comparative observational studies have found better outcomes after coil embolization in these locations. 11, 23 Aneurysms in the cavernous segment of the internal carotid artery are also difficult to treat with surgery 66 but may be relatively easily treated with coil embolization, 67 and both treatments can lead to reduction in compressive symptoms. 61 
Aneurysm Size
For both surgery and endovascular therapy, aneurysm size has been associated with an increase in risk of complications and a decreased likelihood of complete occlusion. The risks of disability and mortality with surgery versus endovascular coiling were greater for giant aneurysms Ͼ25 mm in a meta-analysis of studies of unruptured aneurysms. 16 A similar association has been reported in some series of aneurysms treated by coil embolization. 68, 69 Complete occlusion is less frequently obtainable for larger aneurysms, and additional embolizations are often required during follow-up. 40, 47, 51, 70 Very small aneurysms, such as those with diameter Ͻ3 mm, are also difficult to treat by coil embolization, and intraoperative rupture may be more frequent. 48 However, comparative studies have not evaluated the impact of size on outcomes.
In several studies, aneurysm neck size has been a predictor of the likelihood of complete occlusion by coil embolization, particularly when considered relative to the size of the aneurysm. 70 -73 A neck diameter of Ͻ5 mm and a ratio of neck diameter to largest aneurysm dimension of Ͻ0.5 have been associated with better outcomes, in terms of both rates of complications and likelihood of complete occlusion by coil embolization. 71 In studies of surgical outcomes, neck size has not been reported as an independent predictor of successful clipping or outcomes.
Comorbid Medical Conditions
Comorbid medical conditions and complications from an initial subarachnoid hemorrhage may also influence the selection of surgery or endovascular therapy. For example, the presence of a large parenchymal hematoma with mass effect may favor a decision to perform open surgery to reduce intracranial pressure by surgical evacuation of the hematoma. By contrast, a poor Hunt-Hess grade or evidence of significant brain swelling without a mass lesion may increase the risk of surgical retraction 74 but has less influence on the difficulty of coil embolization treatment. 75 
Technological Advances
Advances in technology are likely to alter the proportion of aneurysms that are treatable by endovascular techniques. Advances in coil technology-such as the introduction of coils with complex shapes and 3-dimensional structures, ultrasoft coils, 76 and liquid polymer techniques 77 -and development of techniques using balloons 78 -82 and intravascular stents [83] [84] [85] [86] [87] [88] [89] [90] to support coil occlusion are examples of improvements that have broadened the appropriate indications for coil embolization. Improvements in surgical equipment and techniques have also occurred in the last decade 1 and are likely to continue.
The skills of the treating practitioner and institution are important. Outcomes of endovascular coil embolization improve with the experience of the practitioners, 49 and a similar association is likely with surgery. 91 In studies of administrative data, institutions that treated a greater number of intracranial aneurysms had better outcomes, 12, 91 and outcomes improved in more recent years. 12 Selecting appropriate candidates for surgery and endovascular coil embolization is a complex process that involves integration of information about the patient's medical condition, the aneurysm's characteristics, evolving techniques and equipment, and the skills and experience of available practitioners.
Follow-Up Imaging After Coil Embolization
An aneurysm may grow or recanalize after coil embolization. 17 This may occur even in aneurysms that appear completely occluded after initial treatment. 48, 58 Further embolization is possible and may be required to prevent growth and potential subarachnoid hemorrhage. 59, 60 Follow-up imaging provides an opportunity to identify inadequately treated aneurysms before subarachnoid hemorrhage or other symptoms occur. A variable number of aneurysms will require additional treatment after initial coil embolization. When completion of treatment is not possible with coil embolization, surgery may be indicated. 92 No data are available to define the appropriate timing of follow-up imaging. After apparent complete occlusion, many practitioners prescribe a follow-up angiogram at 6 months, with additional follow-up imaging based on aneurysm appearance. If complete occlusion is not possible, follow-up imaging is often obtained more frequently.
Catheter angiography has been the preferred imaging modality for follow-up after coil embolization. Given the small risk of permanent complications with catheter angiography-recently estimated as Ͻ0.1% in this setting 93, 94 -and its cost, a noninvasive screening test to identify patients with recanalization after coil embolization is highly desirable but is complicated by the characteristics of the platinum coils. Although MR angiography can identify a residual aneurysmal neck, 95 platinum coils are associated with artifacts that preclude reliable imaging of treated aneurysms with MR and CT angiography. Plain skull x-rays may identify patients with aneurysm recanalization. In a study of 82 treated aneurysms, evidence of coil compaction on skull x-rays identified all patients who were confirmed to have return of flow into an aneurysm by angiography. 96 No other studies have tested the reliability of skull x-rays in this setting.
Indications for Parent Artery Occlusion
An intracranial aneurysm can be treated by occluding the parent artery-the artery from which it arises. However, occlusion of intracranial arteries may lead to ischemia. The ischemic consequences of parent artery occlusion can be predicted by temporarily inflating a balloon to occlude the vessel and evaluating effects on brain function and hemodynamics. [97] [98] [99] However, ischemic sequelae may still occur even in those who tolerate a test occlusion, 98, 99 even if an extracranial-to-intracranial arterial bypass is performed. 100 Parent arteries can be occluded using surgical clips or using endovascular techniques. Endovascular occlusion can be performed simply, as an extension of a test occlusion. Compressive symptoms from the aneurysm are often relieved after parent artery occlusion, 101, 102 presumably by reducing the pressure and by retraction of any blood clot within the aneurysm. This approach has been used most commonly for aneurysms that cannot be treated by direct surgical clipping or coil embolization when the risk of not treating is very high. 101, 102 Recommendations Given the absence of data from randomized trials, all recommendations are based on expert opinion. Endovascular coil embolization is an option for treatment of ruptured and unruptured intracranial aneurysms. Special consideration for coil embolization should be given when surgery is impossible or is high risk. This may include patients with aneurysms in the posterior circulation. Results of a randomized trial are required to define the appropriate role of endovascular coil embolization in the treatment of patients who are candidates for surgery.
Endovascular occlusion of the artery from which an aneurysm arises is a treatment option when an aneurysm cannot be treated directly with surgery or endovascular coil embolization and when that aneurysm is at high risk for subsequent rupture or when neurological symptoms are progressive.
All patients whose aneurysms are treated by coil embolization should have follow-up catheter angiography performed 1 to 6 months after initial treatment. Follow-up imaging should occur sooner in patients with aneurysms that are not completely occluded. Subsequent angiography should be performed in patients whose aneurysms remain incompletely occluded.
Synthesis and Conclusions
The current literature on endovascular therapy consists of reports of cohort studies, case series, and 1 pilot randomized trial, so evidence about the role of endovascular therapy of intracranial aneurysms is limited. Although the literature suggests that endovascular therapy has an important role in treating aneurysms that are difficult to treat by surgery, results of a randomized trial are necessary to establish the relative indications of these 2 approaches.
